يعرض 1 - 6 نتائج من 6 نتيجة بحث عن '"Mayer, Ingrid A"', وقت الاستعلام: 0.90s تنقيح النتائج
  1. 1
    دورية أكاديمية
    Adjuvant platinum versus capecitabine for residual, invasive, triple-negative breast cancer: Patient-reported outcomes in ECOG-ACRIN EA1131.

    المؤلفون: Smith, Karen L., Fengmin Zhao, Mayer, Ingrid A., Tevaarwerk, Amye J., Garcia, Sofia F., Arteaga, Carlos L., Symmans, William F., Park, Ben H., Burnette, Brian L., Makower, Della F., Block, Margaret, Morley, Kimberly A., Jani, Chirag R., Mescher, Craig, Dewani, Shabana J., Brown-Glaberman, Ursa, Flaum, Lisa E., Mayer, Erica L., Sikov, William M., Rodler, Eve T.

    المصدر: Cancer (0008543X); 5/15/2024, Vol. 130 Issue 10, p1447-1757, 11p

    مصطلحات موضوعية: TRIPLE-negative breast cancer, PATIENT reported outcome measures, PATIENT experience, PATIENTS' attitudes, PLATINUM


    أضف إلى المفضلة
  2. 2
    دورية أكاديمية
    Triple-Negative Breast Cancer: Breast Tumors With an Identity Crisis.

    المؤلفون: Nunnery, Sara E., Mayer, Ingrid A., Balko, Justin M.

    المصدر: Cancer Journal; Jan/Feb2021, Vol. 27 Issue 1, p2-7, 6p


    أضف إلى المفضلة
  3. 3
    دورية أكاديمية
    Reciprocal expression of Annexin A6 and RasGRF2 discriminates rapidly growing from invasive triple negative breast cancer subsets.

    المؤلفون: Korolkova, Olga Y., Widatalla, Sarrah E., Whalen, Diva S., Nangami, Gladys N., Abimbola, Adeniyi, Williams, Stephen D., Beasley, Heather K., Reisenbichler, Emily, Washington, Mary Kay, Ochieng, Josiah, Mayer, Ingrid A., Lehmann, Brian D., Sakwe, Amos M.

    المصدر: PLoS ONE; 4/16/2020, Vol. 15 Issue 4, p1-22, 22p

    مصطلحات موضوعية: TRIPLE-negative breast cancer, IMMUNOSTAINING

    النص الكامل

    أضف إلى المفضلة
  4. 4
    دورية أكاديمية
    Sacituzumab govitecan (IMMU-132), an anti-Trop-2-SN-38 antibody-drug conjugate for the treatment of diverse epithelial cancers: Safety and pharmacokinetics.

    المؤلفون: Ocean, Allyson J., Starodub, Alexander N., Bardia, Aditya, Vahdat, Linda T., Isakoff, Steven J., Guarino, Michael, Messersmith, Wells A., Picozzi, Vincent J., Mayer, Ingrid A., Wegener, William A., Maliakal, Pius, Govindan, Serengulam V., Sharkey, Robert M., Goldenberg, David M.

    المصدر: Cancer (0008543X); Oct2017, Vol. 123 Issue 19, p3843-3854, 13p

    مصطلحات موضوعية: CARCINOMA, ANTIBODY-drug conjugates, ANTINEOPLASTIC agents, TRIPLE-negative breast cancer, CELL surface antigens, PHARMACOKINETICS, MEDICATION safety, THERAPEUTICS, CAMPTOTHECIN, CELL adhesion molecules, CLINICAL trials, COMPARATIVE studies, IMMUNOGLOBULINS, RESEARCH methodology, MEDICAL cooperation, MONOCLONAL antibodies, NEUTROPENIA, RESEARCH, TIME, TRANSFERASES, TUMOR antigens, TUMORS, EVALUATION research, TREATMENT effectiveness

    النص الكامل

    أضف إلى المفضلة
  5. 5
    دورية أكاديمية
    Molecular Heterogeneity of Triple-Negative Breast Cancer.

    المؤلفون: Abramson, Vandana, Mayer, Ingrid

    المصدر: Current Breast Cancer Reports; Sep2014, Vol. 6 Issue 3, p154-158, 5p


    أضف إلى المفضلة
  6. 6
    دورية أكاديمية
    Systemic Inflammation After Radiation Predicts Locoregional Recurrence, Progression, and Mortality in Stage II-III Triple-Negative Breast Cancer.

    المؤلفون: Sherry, Alexander D.1 (AUTHOR), von Eyben, Rie2 (AUTHOR), Newman, Neil B.3 (AUTHOR), Gutkin, Paulina2 (AUTHOR), Mayer, Ingrid4 (AUTHOR), Horst, Kathleen2 (AUTHOR), Chakravarthy, A. Bapsi3 (AUTHOR), Rafat, Marjan1,3,5,6 (AUTHOR) marjan.rafat@vanderbilt.edu

    المصدر: International Journal of Radiation Oncology, Biology, Physics. Sep2020, Vol. 108 Issue 1, p268-276. 9p.

    مصطلحات موضوعية: *TRIPLE-negative breast cancer, *CANCER invasiveness, *RADIOTHERAPY, *RADIATION, *BIOMARKERS, *DISEASE progression, *RELATIVE medical risk, *INFLAMMATION, *CANCER relapse, *PROGNOSIS, *TUMOR classification, *RESEARCH funding, *BREAST tumors, *DISEASE complications


    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث